DD
Therapeutic Areas
Mereo BioPharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Setrusumab (UX-143) | Osteogenesis Imperfecta | Phase 3 |
| Alvelestat (MPH966) | Alpha-1 Antitrypsin Deficiency-associated Lung Disease | Phase 2 |
| Etigilimab (MPH313) | Advanced Solid Tumors | Phase 1b |
| Leflutrozole (MPH-220) | Hypogonadotropic Hypogonadism | Phase 2b |